Sabra Healthcare REIT, Inc. (NASDAQ: SBRA - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the fourteen brokerages that are presently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12-month price
Squarepoint Ops LLC cut its position in Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 93.6% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,868 shares of the real estate investment trust's stock after selling 157,633 shares during the quarter.
Tidal Investments LLC lifted its stake in Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 204.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 37,958 shares of the real estate investment trust's stock after acquiring an additional 25,477 shares during the quarter. Tidal
Sabra Health Care REIT remains a Buy, supported by improving fundamentals and an attractive valuation amid a strategic pivot to managed senior housing. SBRA reported Q2 2026 normalized AFFO of $0.40 per share, a ~5% YoY increase, with occupancy rising to 85.4% and guidance reaffirmed. Significant investments—$599 million YTD at ~7.5% yield—position SBRA for the Silver Tsunami, despite near-term macro and rate headwinds.
Sabra Health Care REIT is rated 'Buy' with a $24.50/share price target, reflecting undervaluation and strong fundamentals. SBRA reported robust Q2 results: 24.7% revenue growth, 13.7% same-store managed senior housing NOI growth, and reaffirmed 2026 AFFO guidance. Recent acquisitions totaling $599 million at attractive yields, a healthy balance sheet, and ample liquidity support ongoing external growth.
Senior Housing REITs are outperforming major indices, driven by a persistent supply-demand imbalance and favorable demographic trends. This article previews 3 Senior Housing REITs that offer high yields and strong balance sheets while trading at attractive FFO multiples. All three REITs present robust internal and external growth potential as occupancy rates climb, with yields well above Treasury rates.
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #SBRA--In conjunction with upcoming investor meetings, Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has issued a business update, which is available on the company's website.In addition, Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Chief Investment Officer, and Lukas Hartwich, the company's Executive Vice President of Finance, will participate in the BofA Securities 2026 Gl.
Amundi increased its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 22.7% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 182,620 shares of the real estate investment trust's stock after buying an additional 33,787 shares during
Wall Street analysts made some dramatic moves on Thursday, slashing price targets by double digits on several high-profile names while upgrading others to buy. Find out which stocks got the most surprising treatment before the opening bell.
Sabra Health Care REIT, Inc. (SBRA) Q2 2026 Earnings Call Transcript
